Blair William & CO Pds Biotechnology Corp Transaction History
Blair William & CO
- $32.2 Billion
- Q1 2025
A detailed history of Blair William & CO transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Blair William & CO holds 257,200 shares of PDSB stock, worth $408,948. This represents 0.0% of its overall portfolio holdings.
Number of Shares
257,200
Previous 157,500
63.3%
Holding current value
$408,948
Previous $256,000
19.53%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PDSB
# of Institutions
55Shares Held
8.24MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$7.03 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$774,2770.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$696,2300.0% of portfolio
-
Ubs Group Ag251KShares$399,3380.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $45.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...